| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 156, Issue 2 636-643, Copyright © 1996 by American Association of Immunologists
ARTICLES |
IA Khan, T Matsuura, S Fonseka and LH Kasper
Department of Medicine, Dartmouth Medical School, Hanover, NH 03755, USA.
Production of nitric oxide (NO) by macrophages is important for the killing of intracellular pathogens. IFN-gamma and LPS stimulate NO production by transcriptional up-regulation of inducible nitric oxide synthetase (iNOS). In the present study we used mice with a targeted disruption of the IFN regulatory factor-1 gene (IRF-1-/-) to investigate the importance of NO in the host immune response against Toxoplasma gondii, a major cause of infection in newborns and those with AIDS. IRF-1-/- mice were more susceptible to acute Toxoplasma infection, and treatment with either exogenous IFN-gamma or in vivo neutralization of endogenous IFN-gamma had little effect on their susceptibility to infection. However, administration of exogenous IL-12 was able to prolong survival even when IFN-gamma was depleted. An in vivo depletion study suggested that the mechanism of this protective response is mediated in part by CD4+ T cells. The administration of IL- 12 could not overcome the inhibition of lymphoproliferative response in T. gondii-infected mice and treatment with N-monomethyl-L-arginine (L- NMMA), a nitric oxide synthase (iNOS) antagonist in vitro was unable to reverse the immunosuppression. In response to Toxoplasma infection, splenocytes from IRF-1-/- mice exhibited increased production of IL-10 as well as a 30-fold increase in its message expression. These studies indicate that NO may not be essential for host immunity to the parasite, and moreover that IL-12 appears to induce an IFN-gamma- independent mechanism of protection against this opportunistic pathogen.
This article has been cited by other articles:
|
|
 |
|
  H. Negishi, Y. Fujita, H. Yanai, S. Sakaguchi, X. Ouyang, M. Shinohara, H. Takayanagi, Y. Ohba, T. Taniguchi, and K. Honda Evidence for licensing of IFN-{gamma}-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program PNAS, October 10, 2006; 103(41): 15136 - 15141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Subauste and M. Wessendarp CD40 Restrains In Vivo Growth of Toxoplasma gondii Independently of Gamma Interferon Infect. Immun., March 1, 2006; 74(3): 1573 - 1579. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Andrade, M. Wessendarp, J.-A. C. Portillo, J.-Q. Yang, F. J. Gomez, J. E. Durbin, G. A. Bishop, and C. S. Subauste TNF Receptor-Associated Factor 6-Dependent CD40 Signaling Primes Macrophages to Acquire Antimicrobial Activity in Response to TNF-{alpha} J. Immunol., November 1, 2005; 175(9): 6014 - 6021. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Andrade, J.-A. C. Portillo, M. Wessendarp, and C. S. Subauste CD40 Signaling in Macrophages Induces Activity against an Intracellular Pathogen Independently of Gamma Interferon and Reactive Nitrogen Intermediates Infect. Immun., May 1, 2005; 73(5): 3115 - 3123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. Gavrilescu, B. A. Butcher, L. Del Rio, G. A. Taylor, and E. Y. Denkers STAT1 Is Essential for Antimicrobial Effector Function but Dispensable for Gamma Interferon Production during Toxoplasma gondii Infection Infect. Immun., March 1, 2004; 72(3): 1257 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Andrade, M. Wessendarp, and C. S. Subauste CD154 Activates Macrophage Antimicrobial Activity in the Absence of IFN-{gamma} through a TNF-{alpha}-Dependent Mechanism J. Immunol., December 15, 2003; 171(12): 6750 - 6756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Fachado, A. Rodriguez, J. Molina, J. C. Silverio, A. P. M. P. Marino, L. M. O. Pinto, S. O. Angel, J. F. Infante, Y. Traub-Cseko, R. R. Amendoeira, et al. Long-Term Protective Immune Response Elicited by Vaccination with an Expression Genomic Library of Toxoplasma gondii Infect. Immun., September 1, 2003; 71(9): 5407 - 5411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-S. Mun, F. Aosai, K. Norose, M. Chen, L.-X. Piao, O. Takeuchi, S. Akira, H. Ishikura, and A. Yano TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection Int. Immunol., September 1, 2003; 15(9): 1081 - 1087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Cuesta, C. A. Salkowski, K. E. Thomas, and S. N. Vogel Regulation of Lipopolysaccharide Sensitivity by IFN Regulatory Factor-2 J. Immunol., June 1, 2003; 170(11): 5739 - 5747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ko, A. Gendron-Fitzpatrick, T. A. Ficht, and G. A. Splitter Virulence Criteria for Brucella abortus Strains as Determined by Interferon Regulatory Factor 1-Deficient Mice Infect. Immun., December 1, 2002; 70(12): 7004 - 7012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ko, A. Gendron-Fitzpatrick, and G. A. Splitter Susceptibility of IFN Regulatory Factor-1 and IFN Consensus Sequence Binding Protein-Deficient Mice to Brucellosis J. Immunol., March 1, 2002; 168(5): 2433 - 2440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Silva, C. V. Rodrigues, M. M. Santoro, L. F. L. Reis, J. I. Alvarez-Leite, and R. T. Gazzinelli Expression of Indoleamine 2,3-Dioxygenase, Tryptophan Degradation, and Kynurenine Formation during In Vivo Infection with Toxoplasma gondii: Induction by Endogenous Gamma Interferon and Requirement of Interferon Regulatory Factor 1 Infect. Immun., February 1, 2002; 70(2): 859 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Moretto, L. Casciotti, B. Durell, and I. A. Khan Lack of CD4+ T Cells Does Not Affect Induction of CD8+ T-Cell Immunity against Encephalitozoon cuniculi Infection Infect. Immun., November 1, 2000; 68(11): 6223 - 6232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q.-P. Liu, K. Fruit, J. Ward, and P. H. Correll Negative Regulation of Macrophage Activation in Response to IFN-{gamma} and Lipopolysaccharide by the STK/RON Receptor Tyrosine Kinase J. Immunol., December 15, 1999; 163(12): 6606 - 6613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S.-P. Tan, C. Feng, Y. Asano, and A. U. Kara Altered Immune Response of Interferon Regulatory Factor 1-Deficient Mice against Plasmodium berghei Blood-Stage Malaria Infection Infect. Immun., May 1, 1999; 67(5): 2277 - 2283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yoneto, T. Yoshimoto, C.-R. Wang, Y. Takahama, M. Tsuji, S. Waki, and H. Nariuchi Gamma Interferon Production Is Critical for Protective Immunity to Infection with Blood-Stage Plasmodium berghei XAT but Neither NO Production nor NK Cell Activation Is Critical Infect. Immun., May 1, 1999; 67(5): 2349 - 2356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Ely, L. H. Kasper, and I. A. Khan Augmentation of the CD8+ T Cell Response by IFN-{gamma} in IL-12-Deficient Mice During Toxoplasma gondii Infection J. Immunol., May 1, 1999; 162(9): 5449 - 5454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Y. Denkers and R. T. Gazzinelli Regulation and Function of T-Cell-Mediated Immunity during Toxoplasma gondii Infection Clin. Microbiol. Rev., October 1, 1998; 11(4): 569 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Holscher, G. Kohler, U. Muller, H. Mossmann, G. A. Schaub, and F. Brombacher Defective Nitric Oxide Effector Functions Lead to Extreme Susceptibility of Trypanosoma cruzi-Infected Mice Deficient in Gamma Interferon Receptor or Inducible Nitric Oxide Synthase Infect. Immun., March 1, 1998; 66(3): 1208 - 1215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zhou, G. Miller, and R. A. Seder Factors Involved in Regulating Primary and Secondary Immunity to Infection with Histoplasma capsulatum: TNF-{alpha} Plays a Critical Role in Maintaining Secondary Immunity in the Absence of IFN-{gamma} J. Immunol., February 1, 1998; 160(3): 1359 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. A. Khan, J. D. Schwartzman, T. Matsuura, and L. H. Kasper A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice PNAS, December 9, 1997; 94(25): 13955 - 13960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Scharton-Kersten, C. Contursi, A. Masumi, A. Sher, and K. Ozato Interferon Consensus Sequence Binding Protein-deficient Mice Display Impaired Resistance to Intracellular Infection Due to a Primary Defect in Interleukin 12 p40 Induction J. Exp. Med., November 3, 1997; 186(9): 1523 - 1534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Scharton-Kersten, G. Yap, J. Magram, and A. Sher Inducible Nitric Oxide Is Essential for Host Control of Persistent but Not Acute Infection with the Intracellular Pathogen Toxoplasma gondii J. Exp. Med., April 7, 1997; 185(7): 1261 - 1274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Fehr, G. Schoedon, B. Odermatt, T. Holtschke, M. Schneemann, M. F. Bachmann, T. W. Mak, I. Horak, and R. M. Zinkernagel Crucial Role of Interferon Consensus Sequence Binding Protein, but neither of Interferon Regulatory Factor 1 nor of Nitric Oxide Synthesis for Protection Against Murine Listeriosis J. Exp. Med., March 3, 1997; 185(5): 921 - 932. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
